Related Experiment Videos
Interleukin-6 and "complex" cardiac myxoma
Y Mochizuki1, Y Okamura, H Iida
1Department of Thoracic and Cardiovascular Surgery, Dokkyo University School of Medicine, Tochigi, Japan. mochi@dokkyomed.ac.jp
Insights
A rare complex cardiac myxoma case presented with constitutional symptoms due to excess interleukin-6. Surgical removal of the tumor normalized interleukin-6 levels, indicating its role in the condition.
Area of Science:
- Cardiology
- Oncology
- Immunology
Background:
- Cardiac myxomas are typically benign tumors, but complex types can present with systemic symptoms.
- Constitutional signs in complex cardiac myxomas are often linked to cytokine overproduction.
- Interleukin-6 (IL-6) is implicated in the pathogenesis of systemic manifestations of cardiac myxomas.
Observation:
- A rare case of complex cardiac myxoma was documented.
- The patient exhibited pronounced constitutional signs.
- Immunohistochemical analysis revealed strong interleukin-6 positivity within the myxoma tissue.
Findings:
- Elevated serum interleukin-6 levels were observed in the patient.
- Surgical resection of the cardiac myxoma led to a significant decrease in serum IL-6.
- Serum IL-6 levels remained undetectable post-surgery for two years.
Implications:
- This case highlights the significant role of interleukin-6 in the systemic effects of complex cardiac myxomas.
- It suggests that IL-6 levels can serve as a biomarker for disease activity and treatment response.
- The findings support the complete surgical excision of cardiac myxomas to manage associated constitutional symptoms.
Abstract:
A rare case of "complex" cardiac myxoma is reported. Complex cardiac myxoma manifests with more constitutional signs than the sporadic type. These constitutional signs are known to be associated with the overproduction of interleukin-6 by cardiac myxomas. In our study, immunohistochemical staining of the myxoma for interleukin-6 was strongly positive. The serum interleukin-6 level decreased after surgical removal of the tumor and has remained undetectable for the past 2 years.